Research & Development in the
Canton of Geneva

Fondation C.R.E.S., Centre de Recherches Entreprises et Sociétés

Since 1996 · 11–20 empl.

Fondation C.R.E.S., Centre de Recherches Entreprises et Sociétés studies the economic, political, religious and social environments of countries where companies may operate. It convenes experts and decision-makers for analysis and dialogue, examines geopolitical changes, and maintains an information and exchange network.

Selexis SA

Since 2001 · 1–10 empl.

Selexis SA develops and provides technologies and services for mammalian cell line development, with a focus on biopharmaceutical production. The company also presents its SUREtechnology platform for stable CHO-based cell line development.

e-novent SA

Since 2001 · 1–10 empl.

e-novent SA is an engineering firm that supports technical innovation projects and provides services including problem identification and analysis, solution development, feasibility and patentability studies, and implementation support.

World Heart Federation

Since 2003 · 21–50 empl.

The company's core activity is to promote global heart health by improving the prevention, diagnosis, and treatment of cardiovascular diseases. The company is engaged in research, education, and advocacy to promote heart health for all people, regardless of race, nationality, gender, age, education, or income. It works with partners to develop programs and initiatives that improve heart health and reduce the impact of cardiovascular diseases.

Fondation pour la recherche de la cardiologie universitaire de Genève (GECOR)

Since 2003 · 11–20 empl.

Fondation pour la recherche de la cardiologie universitaire de Genève (GECOR) supports research projects and scientific exchange in the field of cardiovascular diseases to benefit the Division of Cardiology of the Hôpitaux Universitaires de Genève (HUG), its clinical activities and its research laboratories. It funds and assists both clinical and basic research, including work on cardiovascular prevention, therapeutic education and heart failure, and on inflammation, atherosclerosis, myocardial metabolism and cardiovascular genetics.

Drugs for Neglected Diseases initiative (DNDi)

Since 2003 · 101–500 empl.

The company's core activity is the development and provision of medical treatments, particularly for neglected tropical diseases (NTDs) and viral diseases, including pandemic and climate-related diseases. The company focuses on developing new treatments to improve accessibility and affordability for patients in low- and middle-income countries.

Mandat International alias Fondation pour la Coopération Internationale

Since 2004 · 1–10 empl.

The core activity of Mandat International is to carry out research projects and activities in the fields of international cooperation, sustainable development, international law and data protection. The company is particularly involved in researching emerging technologies, promoting multilateral dialogue and cooperation, and upholding academic freedom and human rights.

Windspots Sàrl

Since 2004 · 1–10 empl.

Windspots Sàrl operates the Windspots.com website, which aggregates real-time wind and weather data and images from multiple spots. The service publishes measurements from networked weather stations, provides an API and open-source software, and offers optional paid services and subscription options.

DATA MINING INT SA

Since 2005 · 11–20 empl.

DATA MINING INT SA is an independent research agency providing data mining research and evidence modelling for public and private sector clients. Services include multi‑criteria risk assessment, health technology assessment, value demonstration, process optimisation and applications in big data, artificial intelligence and eHealth.

Wüest Partner AG

Since 2006 · 101–500 empl.

Wüest Partner AG provides services and digital solutions for the real estate sector, including valuation, consulting, software, sustainability services, data and analytics, and education. The firm combines expertise, data and digital tools to deliver decision‑support for valuations, portfolio and asset management, and sustainability and risk analyses.

HiQScreen Sàrl

Since 2007 · 1–10 empl.

The core activity of HiQScreen is the conduct of functional studies on membrane proteins, particularly voltage-dependent channels and ligand-gated ion channels, within the framework of preclinical tests and pharmacological characterizations. To this end, the company offers various services, including automated recordings in Xenopus oocytes, manual patch-clamp techniques, cell culture for transient or stable transfections, synthetic gene designs, and molecular biology services.

LEM INTERNATIONAL SA

Since 2007 · 101–500 empl.

LEM INTERNATIONAL SA develops and manufactures electrical measurement solutions, including current and voltage sensors, integrated transducers, Rogowski coils and energy meters for energy, mobility and industrial applications.

GULF RESEARCH CENTER FOUNDATION

Since 2007 · 21–50 empl.

The core activity of the Gulf Research Center (GRC) encompasses research, analysis, consulting, and education in the field of regional and global affairs, particularly in the Middle East and the Gulf region. The activities of the GRC can be specified as follows: * Research and Analysis: Conducting studies and analyses on regional and global topics to promote knowledge and understanding. * Consulting: Providing expert consulting services to governments and non-governmental organizations in areas of focus for the GRC. * Education: Implementing educational programs and events to train and inform leaders and decision-makers. * Publications: Publishing articles, reports, and other materials on regional and global topics. * Networking: Building and maintaining relationships with international partners and organizations to develop local solutions based on global experiences. Overall, the GRC focuses on providing knowledge, analysis, and consulting to promote regional and global cooperation and support decision-making in the areas of politics, economy, and society.

Fondation pour l'institut de hautes études internationales et du développement

Since 2007 · 51–100 empl.

The company is a higher education institution specializing in the fields of international relations, development research, and global affairs. The core activities include: Teaching: Offering master's and PhD programs as well as executive education programs; Research: Conducting research projects, operating research centers and libraries; Continuing education: Providing executive education programs and events for the international community; Events: Organizing conferences, debates, and other events on global topics. The company's main task is to analyze and understand the impact of globalization, as well as to train the next generation of leaders in international relations and development research.

NXP Semiconductors Switzerland SA

Since 2007 · 51–100 empl.

The core activity of NXP Semiconductors is the development and manufacturing of semiconductor solutions for various markets, particularly in the areas of Automotive, Industrial, Consumer and Communication. The company focuses on developing system solutions that enable long-term, profitable growth, free cash flow and robust capital returns for its owners. Specifically, NXP offers solutions for: Automotive applications such as driver assistance systems, electromobility and infotainment; Industrial applications such as Building Automation, Factory Automation and Healthcare; Consumer goods such as Mobile Devices, Home Appliances and Home Entertainment; and Communication applications such as Wireless Networks and Interfaces. The company invests heavily in research and development to strengthen its market positions in these areas and achieve long-term success.

Solutions Concept Sàrl

Since 2008 · 1–10 empl.

Solutions Concept Sàrl represents DATOptic products in Europe and supplies storage hardware such as external enclosures, rack systems and NAS units, together with related sales and support services.

Bionoltra SA

Since 2008 · 11–20 empl.

The core activity of BIONOLTRA SA is the development, manufacture and marketing of medical devices and products for orthopedics and urology, particularly for the treatment of osteoarthritis and other diseases affecting the musculoskeletal system and urology.

Fondation Sanfilippo Suisse

Since 2008 · 1–10 empl.

The core activity of the company is to promote and support research and help for people with Sanfilippo disease, a rare genetic disorder. The company, Fondation Sanfilippo Suisse, is involved in organizing fundraising campaigns, team-building events and other activities to collect money and attention for the disease. It also provides information about the disease and the research related to it, and enables companies and individuals to engage as partners or donors.

FONDATION AGALMA

Since 2010 · 21–50 empl.

The core activity of the Fondation Agalma consists of conducting interdisciplinary research and organizing seminars, conferences and workshops that focus on the interfaces between neuroscience, psychoanalysis and art. The foundation aims to develop new questions and ideas and to promote exchange between researchers from different disciplines.

Descartes Institute for the Future Sàrl

Since 2011 · 11–20 empl.

The company 'Descartes Institute for the Future' primarily focuses on researching and analyzing future topics, particularly in the areas of innovation, technology, and urban development. The core activity of the company is to provide research and consulting services to private and public organizations to support them in shaping their future viability. The company also creates various rankings and indices, such as the 'Smart City Index', which measures the future viability of cities. Furthermore, the company publishes books, articles, and presentations on topics such as innovation, urban development, and sustainability. Overall, the core activity of the company can be described as 'research and consulting in the field of future development and innovation'.

eKlore Sàrl

Since 2011 · 11–20 empl.

The core activity of eKlore is applied research and development in the field of computer science.

Ali&Co Genève SA

Since 2011 · 1–10 empl.

Ali&Co Genève SA manufactures Swiss made wristwatches and markets them, including the Mysterali collection. The Mysterali models use a patented quartz "mysterious" movement and a transparent dial where the hands appear to move without a visible mechanism.

Neurix SA

Since 2011 · 11–20 empl.

The core activity of Neurix SA is the development and provision of human stem cell-based services for drug discovery and development, particularly in the field of neurology. This includes the creation of 3D neural tissue models, the development of in vitro models for neurodegenerative diseases, and the conduct of high-throughput screenings for the evaluation of drug candidates.

ANTION BIOSCIENCES SA

Since 2011 · 1–10 empl.

ANTION BIOSCIENCES SA develops a proprietary gene engineering technology and a multiplex engineering platform to support development and manufacturing of cell and gene therapy products. The company offers partnering, business development and related services, and publishes scientific work on its technology.

scMetrology SARL

Since 2013 · 1–10 empl.

The core activity of scMetrology SARL is the characterization of superconductors, particularly in the measurement of their electromechanical properties. The company offers services such as measuring critical current as a function of magnetic fields, temperatures, and mechanical stresses. It works closely with the University of Geneva and other laboratories to perform these measurements. Another focus of the company is the development of TMC conductors, which are considered the next generation of high-field superconductors.

FONDATION DE LA TOUR POUR LA RECHERCHE ET L'ENSEIGNEMENT EN ORTHOPEDIE, MEDECINE DU SPORT, TRAUMATOLOGIE ET IMAGERIE DE L'APPAREIL MOTEUR (FORE)

Since 2013 · 1–10 empl.

FONDATION DE LA TOUR POUR LA RECHERCHE ET L'ENSEIGNEMENT EN ORTHOPEDIE, MEDECINE DU SPORT, TRAUMATOLOGIE ET IMAGERIE DE L'APPAREIL MOTEUR (FORE) supports research, education and quality management in orthopedic surgery, sports medicine, traumatology and musculoskeletal imaging. The foundation raises and allocates funds to programmes that advance training, public awareness and the clinical care of children and adults.

M3DC Sàrl

Since 2013 · 1–10 empl.

M3DC Sàrl is an independent scientific management and consulting organization specializing in the creation and management of multidisciplinary, cross‑national R&D projects in drug discovery and development. It provides project and operational management, expert networking, and services for technology‑transfer organisations and operational support to biotech companies.

Global Action For Fungal Infections (GAFFI)

Since 2013 · 21–50 empl.

Global Action For Fungal Infections (GAFFI) is a foundation focused on reducing death and suffering from fungal infections. GAFFI promotes timely diagnosis and access to antifungal treatment in low- and middle-income countries, supports regional hubs and networks, and maintains resources connecting clinicians, researchers, diagnostics providers and policy stakeholders.

APTISSEN SA

Since 2013 · 51–100 empl.

Aptissen develops and distributes medical products, particularly orthobiological solutions for the treatment of muscle and joint pain. The company's core activities include research, development and marketing of products such as Synolis VA and Cartylis, which are used for tissue regeneration and repair.

Fondation Campus Biotech Geneva

Since 2013 · 21–50 empl.

Fondation Campus Biotech Geneva operates Campus Biotech as a life-sciences hub focused on neuroscience, neurotechnology and digital health. The foundation provides research space, scientific platforms and services such as meeting rooms, event organization, catering and prototyping workshops.

Wyss Center for Bio and Neuro Engineering

Since 2014 · 101–500 empl.

The core activity of the Wyss Center is the development and implementation of innovative technologies and therapies in the field of neurology and neuroscience, particularly for the treatment of neurological and psychiatric disorders. This includes research and development of new technologies, support for start-ups, and collaboration with industry partners to bring these innovations into clinical practice. The Wyss Center combines experts from various disciplines such as neuroscience, engineering, software development, and data analysis to develop transformative solutions.

DONA Foundation

Since 2014 · 21–50 empl.

The core activity of DONA Foundation is the development, standardization and management of Digital Object Architecture (DOA) and Handle System, a system for identifying and managing digital objects. The company promotes the use of DOA and Handle System in various industries and supports the development of applications and tools based on this technology.

Eoswiss-Engineering SARL

Since 2014 · 1–10 empl.

The core activity of Eoswiss is the provision of services and development of products for the pharmaceutical and biotechnology industries, particularly in the areas of: * Technology transfer and production transfer * Process development and scale-up * Supply chain management and efficiency enhancement * Quality management and GMP (Good Manufacturing Practice) * Project management The company also offers specific products and services such as: * Intelligent scale-up process development and digitalization * Process optimization * Precise freeze-drying * Polarized light - optical inspection * Process analytical technology (PAT) and AI (Artificial Intelligence) * Virtual factory simulation The company positions itself as an expert in interdisciplinary projects in the pharmaceutical and biotechnology industries.

SPACECODE Diamonds SA

Since 2014 · 21–50 empl.

The core activity of Spacecode is the development and provision of intelligent inventory management solutions for the high-end industries of diamonds, jewelry and healthcare. This includes the combination of RFID-controlled hardware, unique LED tags and customized software to provide advanced solutions for inventory management, diamond identification and process automation.

CELL RECEPTOR SA

Since 2015 · 1–10 empl.

CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.

La Fondation Apprendre Genève

Since 2016 · 11–20 empl.

The core activity of The Geneva Learning Foundation is to conduct research, development and scaling of new learning and leadership approaches to address critical threats to society. The company focuses on creating collective capacity for transformation and supporting organizations in addressing challenges through innovative learning and leadership approaches.

KYLANE LABORATOIRES SA

Since 2016 · 1–10 empl.

The core activity of Kylane Laboratoires is the development, manufacture and marketing of innovative, hyaluronic acid (HA) based solutions for aesthetic medicine, particularly for the treatment of the face and body.

Procter & Gamble Retail Services Sàrl

Since 2017 · 51–100 empl.

The core activity of Procter & Gamble (P&G) is the development, manufacture and marketing of consumer goods, particularly daily used products such as household and personal care items, food and other consumer goods. The company focuses on creating high-quality products and services that are used and valued by people all over the world.